Report overview
Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people routine immunization results in more than 95% of people being protected.
This report contains market size and forecasts of Hepatitis B Vaccination in global, including the following market information:
Global Hepatitis B Vaccination Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hepatitis B Vaccination Market Sales, 2017-2022, 2023-2028, (Units)
Global top five Hepatitis B Vaccination companies in 2021 (%)
The global Hepatitis B Vaccination market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Yeast Derived Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hepatitis B Vaccination include GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, KM Biologics, LG Life Sciences and Serum Institute. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hepatitis B Vaccination manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hepatitis B Vaccination Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Hepatitis B Vaccination Market Segment Percentages, by Type, 2021 (%)
Yeast Derived
CHO Derived
Global Hepatitis B Vaccination Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Hepatitis B Vaccination Market Segment Percentages, by Application, 2021 (%)
Children
Adult
Global Hepatitis B Vaccination Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Units)
Global Hepatitis B Vaccination Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hepatitis B Vaccination revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hepatitis B Vaccination revenues share in global market, 2021 (%)
Key companies Hepatitis B Vaccination sales in global market, 2017-2022 (Estimated), (Units)
Key companies Hepatitis B Vaccination sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
